| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5540918 | ALCON PHARMS LTD | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
Jul, 2013
(10 years ago) | |
|
US5540918 (Pediatric) | ALCON PHARMS LTD | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
Jan, 2014
(10 years ago) | |
Betaxon is owned by Alcon Pharms Ltd.
Betaxon contains Levobetaxolol Hydrochloride.
Betaxon has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Betaxon are:
- US5540918
- US5540918*PED
Betaxon was authorised for market use on 23 February, 2000.
Betaxon is available in suspension/drops;ophthalmic dosage forms.
The generics of Betaxon are possible to be released after 30 January, 2014.
Drugs and Companies using LEVOBETAXOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 23 February, 2000
Treatment: NA
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
BETAXON family patents
